Human neutrophil peptides in vaginitis-cervicitis of different etiology

• Autorzy: Wiechula B E , Friedek D.A. , Ekiel A.M. , Romanik M.K. , Martirosian G.
• Języki publikacji: EN

Abstrakty

EN

Development of female genito-urinary infections depends on many factors, such as immune system activity, virulence of microorganism and production of factors inhibiting the growth of microorganisms. Taking into account the possibility of relapses or severe complications, it is very important to appropriately diagnose and treat infections. Because of recently observed increase of microbial resistance to antibiotics, researchers are looking for alternatives. In our study we evaluated and compared the concentration of human neutrophil peptides (HNP 1-3) in cervico-vaginal lavages (CVL), obtained from women with vaginitis/cervicitis. Swabs from the posterior vaginal fornix and from the endocervical canal as well as CVL samples were obtained from 32 patients with vaginitis/cervicitis and 29 healthy women (control group). Supernatants of CVL were used for determination of concentration of HNP by ELISA. The difference between concentrations of HNP 1-3 in studied and control groups was statistically significant (p=0.018). The maximal concentration was determined in patients with mixed infections (28.41 ng/ml), and Group B Streptococci, GBS, (28.06 ng/ml), the minimal concentrations in cases of C. trachomatis (mean concentrations did not differ from those in the control group: 16.93 ng/ml and 16.39 ng/ml, respectively). Maximal correlation was determined for control-studied group with isolation of GBS (r=0.79), and very high negative correlation for group of GBS - C. trachomatis (r=-0.98).

Słowa kluczowe

EN

microorganism growth; microbial resistance; man; cervicitis; neutrophil peptide; etiology; antibiotic; genitourinary infection; vaginitis; female

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2007
• Tom: 56
• Numer: 3
• Opis fizyczny: p.185-189,fig.,ref.

Twórcy

autor

Wiechula B E

• Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland

autor

Friedek D.A.

autor

Ekiel A.M.

autor

Romanik M.K.

autor

Martirosian G.

Bibliografia

• Choroszy-Król I., J. Ruczkowska, A. Kowal and L. Pawlik. 2000. Detection of Chlamydia trachomatis in urine specimens by using Ligase Chain Reaction (LCR). Adv. Clin. Exp. Med. 9: 245-250.
• Couto M.A., L. Liu, R.I. Lehrer and T. Ganz. 1994. Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin. Infect. Immun. 62: 2375-2378.
• Denys A. 2006. Macrolides in the treatment of genitourinary system infections (in Polish). Gin. Prakt. 3: 6-10.
• Dybaś L, A. Sidor-Wójtowicz and M. Kozioł-Montewka. 2005. Bacterial flora and mycosis of the vagina in women with symptoms of vaginal inflammation (in Polish). Ginekol. Pol. 76: 385-390.
• Fernie-King B.A., D.J. Seilly and P.J. Lachmann. 2006. Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS. Biochem. Soc. Trans. 34: 273-275.
• Ganz T. 2001. Fatal attraction evaded: how pathogenic bacteria resist cationic polypeptides. J. Exp. Med. 193: F31-F34.
• Ganz T., M.E. Selsted, D. Szklarek, S.S. Harwig, K. Daher, D.F. Bainton and R.I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76: 1427-1435.
• Gołąb-Lipińska M. and A. Kurnatowska. 2001. Some aspects of fungi multifocal invasions connected with the genital organs in women (in Polish). Wiad. Parazytol. 47: 137-142.
• Hancock R.E. 1997. Peptide antibiotics. Lancet 349: 418-422.
• Lehrer R.I., T. Ganz, D. Szklarek and M.E. Selsted. 1988. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Invest. 81: 1829-1835.
• Lynn D.J., A.T. Lloyd, M.A. Fares and C. O'Farrelly. 2004. Evidence of positively selected sites in mammalian alpha-defensins. Mol. Biol. Evol. 21: 819-827.
• Nagaoka I., S. Hirota, S. Yomogida, A. Ohwada and M. Hirata. 2000. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49: 73-79.
• Oren Z. and Y. Shai. 1997. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36: 1826-1835.
• Porter E., H. Yang, S. Yavagal, G.C. Preza, O. Murillo, H. Lima, S. Greene, L. Mahoozi, M. Klein-Patel, G. Diamond and others. 2005. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect. Immun. 73: 4823-4833.
• Raj P.A., K.J. Antonyraj and T. Karunakaran. 2000. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347: 633-641.
• Salzman N.H., D. Ghosh, K.M. Huttner, Y. Paterson and C.L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
• Schmidtchen A., I.M. Frick and L. Bjorek. 2001. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial a-defensin. Mol. Microbiol. 39: 708-713.
• Tollin M., P. Bergman, T. Svenberg, H. Jornvall, G.H. Gud-mundsson and B. Agerberth. 2003. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24: 523-530.
• Valore E.V., C.H. Park, S.L. Igreti and T. Ganz. 2002. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 187: 561-568.
• Wiesenfeld H.C., R.P. Heine, M.A. Krohn, S.L. Hillier, A.A. Amortegui, M. Nicoiazzo and R.L. Sweet. 2002. Association between elevated neutrophil defensin levels and endometritis. J. Infect. Dis. 186: 792-797.
• Yang D., A. Biragyn, L.W. Kwak and J.J. Oppenheim. 2002. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23: 291-296.
• Yasin B., S.S. Harwig, R.I. Lehrer and E.A. Wagar. 1996. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect. Immun. 64: 709-713.
• Yeaman M.R. and N.Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev 55: 27-55.
• Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-95.
• Zbroch T., P. Knapp, E. Błońska, M. Kobylec and P. Knapp. 2004. Life style, Chlamydia trachomatis infection, bacterial vaginosis and their impact on the frequency of cervical lesions (in Polish). Ginekol. Pol. 75: 538-544.